Novel Medications for Opiate Detoxification - 4

Yale University

Status and phase: Completed; Phase 2

Conditions: Opioid-Related Disorders; Substance-Related Disorders

Treatments: Drug: Clonidine

Study type: Interventional

Funder types: Other; Other U.S. Federal agency; NIH

Identifiers

NCT00000279

P50DA009250 (U.S. NIH Grant/Contract)

P50-09250-4

NIDA-09250-4

Details and patient eligibility

About

The purpose of this study is to evaluate novel medications for opiate detoxification.

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion and exclusion criteria

Please contact site for information.